Kritika Sarmah: Page 3
Want to write for Entrepreneur too? Apply to join Entrepreneur Leadership network.
Latest: Page 3
GOOGL Earnings Breakdown and Optimizing Your Portfolio Strategy
With Alphabet's (GOOGL) earnings drawing near, investors eagerly await the potential earnings from its key services like Google Search, YouTube ad revenue, and Google Cloud. Join us as we delve...
Is META Preparing for Market Momentum?
Anticipation is high in the market this week as investors look forward to Meta Platforms (META) unveiling its first-quarter results on Wednesday, April 24th. With bullish analysts' estimates and historic...
3 Biotech Stocks to Buy to Power Through April
The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks...
3 Energy Stocks to Accelerate Your Portfolio Gains
Surging oil & natural gas demand and ample technological advancements continue to drive the energy sector's growth and evolution. Amid this backdrop, fundamentally strong energy stocks TotalEnergies (TTE), Cheniere Energy...
4 Biotech Stocks With Massive Buy Potential
The biotech sector is poised for robust long-term growth, driven by significant developments in drug approvals, innovative therapies, and government-backed initiatives. Hence, investors might consider buying fundamentally solid biotech stocks...
Clover Health Investments (CLOV) vs. Cigna (CI): Which Medical Stock is the Bigger Buy?
The ever-rising healthcare costs are boosting the insurance industry in the current economic landscape. While prominent industry players Clover Health (CLOV) and Cigna Group (CI) should benefit, let us analyze...
